BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Artificial Intelligence

Collaborative Open-Source Approaches Are the New Norm in Life Sciences Research, According to Survey

by Illia Petrov   •   June 15, 2023  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# AI & Digital   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and integration of open-source software and public cloud services. New research indicates that these technologies are no longer mere tools, but foundational elements that fuel progress and breakthroughs in the field.

#advertisement
How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

open-source platforms

A recent survey by Seqera Labs, a major provider of secure data orchestration software, surveyed over 500 global researchers and found that approximately 72% of them consider open-source collaboration and workflow management to be fundamental to their work. This staggering statistic illuminates the transformative role these technologies are playing in life sciences research.

Notably, open-source platforms have streamlined the research process, enhancing sequencing capabilities and enabling scientists to avoid duplicative efforts. These advantages extend across all continents, pointing to the global reach and impact of these technologies. Around 41% of the surveyed researchers highlighted the potential of these platforms to facilitate cross-organizational collaboration, a domain traditionally hampered by the protection of intellectual property.

Continue reading

This content available exclusively for BPT Mebmers

 BPT Membership 

Topics: AI & Digital   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.